Company
株式会社NovAccel
NovAccel uses its experience and technology in superconducting accelerators to produce and sell radioisotopes such as actinium-225, which are drawing attention for future cancer treatment.
- Business model
- B2B
- Headquarters
- 土浦市, 茨城県, Japan
- Founded
- 2024
- Legal name
- 株式会社NovAccel
Claim, correct or request removal
Record updated 28 September 2026
About
独自開発の小型超伝導加速器を用いた医療用放射性同位体Ac-225の製造・販売
Products
- Hardware
- RiSA01
- Other
- 医療用ラジオアイソトープ Ac-225
Loading relationship preview